Health SKYRIZI® (risankizumab-rzaa) Receives FDA Approval as the First and Only Specific Interleukin-23 (IL-23) to Treat Moderately to Severely Active Crohn’s Disease in Adults June 17, 2022
Biotechnology Oxford Industries and Flagstar Bancorp have been highlighted as Zacks Bull and Bear of the Day June 17, 2022
Health Global Health Services Company, Cigna, Announces $3.5 Billion Accelerated Stock Repurchase Agreements June 16, 2022
Biotechnology CLASS ACTION UPDATE for BKKT, IIPR and AXSM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders June 16, 2022
Search
Health
June 16, 2022
